Anuv Ratan is a member of the Replay Board of Directors. He joined KKR in 2017 and is a member of the Health Care industry team within the firm’s Americas Private Equity platform. He has been involved with KKR’s investments in Aimmune Therapeutics, Ajax Health, Biosynth Carbosynth, Cordis, Dawn Biopharma, Gamma Biosciences, Headlands Research, Impel Neuropharma, Nordic Bioscience, Sapphiros, and Zeus Health. Prior to joining KKR, Mr. Ratan worked at FFL Partners, where he was involved in a number of health care private equity transactions. Mr. Ratan began his career at The Blackstone Group. He holds an A.B., with honors, in Neurobiology from Harvard University.